Anna M. Wandmacher

Arnold Heller Str. 3
Kiel, SH 24105, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarcinoma.

Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarcinoma.

Journal: NPJ precision oncology

Published: March 13, 2026

Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic cancer.

Novel L1CAM-antibody drug conjugates exert potent anti-tumor activity in preclinical models of even advanced pancreatic cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 21, 2025

Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database.

Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database.

Journal: Targeted oncology

Published: November 12, 2025

Pancreatic Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2024 in Barcelona.

Pancreatic Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2024 in Barcelona.

Journal: Oncology research and treatment

Published: June 10, 2025

Intratumoral microbiome and pancreatic cancer: an enabling hallmark and path to novel treatments?

Intratumoral microbiome and pancreatic cancer: an enabling hallmark and path to novel treatments?

Journal: British journal of cancer

Published: May 08, 2025

The challenge of making the right choice: patient avatars in the era of cancer immunotherapies.

The challenge of making the right choice: patient avatars in the era of cancer immunotherapies.

Journal: Frontiers in immunology

Published: June 09, 2023

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.

Journal: Frontiers in immunology

Published: February 02, 2023

Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors.

Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors.

Journal: International journal of cancer

Published: October 26, 2021

The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer.

The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer.

Journal: Cancers

Published: August 26, 2021

Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer.

Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer.

Journal: Cancers

Published: July 23, 2021

MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer.

MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer.

Journal: Nature communications

Published: June 22, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026